Cargando…
The current state of the osteoarthritis drug development pipeline: a comprehensive narrative review of the present challenges and future opportunities
In this narrative review article, we critically assess the current state of the osteoarthritis (OA) drug development pipeline. We discuss the current state-of-the-art in relation to the development and evaluation of candidate disease-modifying OA drugs (DMOADs) and the limitations associated with th...
Autores principales: | Kim, Heungdeok, Seo, Jinwon, Lee, Yunsin, Park, Kiwon, Perry, Thomas A., Arden, Nigel K., Mobasheri, Ali, Choi, Heonsik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732806/ https://www.ncbi.nlm.nih.gov/pubmed/36504595 http://dx.doi.org/10.1177/1759720X221085952 |
Ejemplares similares
-
Strategic application of imaging in DMOAD clinical trials: focus on eligibility, drug delivery, and semiquantitative assessment of structural progression
por: Guermazi, Ali, et al.
Publicado: (2023) -
Regenerative medicine for early osteoarthritis
por: Im, Gun-Il, et al.
Publicado: (2023) -
Emerging molecular biomarkers in osteoarthritis pathology
por: Sandhu, Amit, et al.
Publicado: (2023) -
Circulating microRNAs differentiate fast-progressing from slow-progressing and non-progressing knee osteoarthritis in the Osteoarthritis Initiative cohort
por: Ali, Shabana Amanda, et al.
Publicado: (2022) -
Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs)
por: Oo, Win Min, et al.
Publicado: (2022)